546 results on '"Leung, Euphemia"'
Search Results
2. SARS-CoV-2 evolution has increased resistance to monoclonal antibodies and first-generation COVID-19 vaccines: Is there a future therapeutic role for soluble ACE2 receptors for COVID-19?
3. The autoimmune rheumatological presentation of Common Variable Immunodeficiency Disorders with an overview of genetic testing
4. Challenges for gene editing in common variable immunodeficiency disorders: Current and future prospects
5. Functionalisation of extracellular vesicles with cyclic-RGDyC potentially for glioblastoma targeted intracellular drug delivery
6. The Rapidly Expanding Genetic Spectrum of Common Variable Immunodeficiency–Like Disorders
7. Selective IgA Deficiency May Be an Underrecognized Risk Factor for Severe COVID-19
8. SARS-CoV-2 Omicron: Light at the End of the Long Pandemic Tunnel or Another False Dawn for Immunodeficient Patients?
9. Validating TDP1 as an Inhibition Target for the Development of Chemosensitizers for Camptothecin-Based Chemotherapy Drugs
10. Common Variable Immunodeficiency Disorders, T-Cell Responses to SARS-CoV-2 Vaccines, and the Risk of Chronic COVID-19
11. Development of 2-Morpholino-N-hydroxybenzamides as anti-proliferative PC-PLC inhibitors
12. Identification of novel Atg3-Atg8 inhibitors using virtual screening for autophagy modulation
13. Improving the solubility of anti-proliferative thieno[2,3-b]quinoline-2-carboxamides
14. Liposome-enabled bufalin and doxorubicin combination therapy for trastuzumab-resistant breast cancer with a focus on cancer stem cells.
15. Characterizing Extracellular Vesicles Generated from the Integra CELLine Culture System and Their Endocytic Pathways for Intracellular Drug Delivery.
16. The SMAC mimetic LCL161 is a direct ABCB1/MDR1-ATPase activity modulator and BIRC5/Survivin expression down-regulator in cancer cells
17. Development, synthesis and biological investigation of a novel class of potent PC-PLC inhibitors
18. Discovery of novel phosphatidylcholine-specific phospholipase C drug-like inhibitors as potential anticancer agents
19. Recent Advancement and Technical Challenges in Developing Small Extracellular Vesicles for Cancer Drug Delivery
20. Syntheses of mono-acylated luteolin derivatives, evaluation of their antiproliferative and radical scavenging activities and implications on their oral bioavailability
21. Can intracellular drug delivery using hyaluronic acid functionalised pH-sensitive liposomes overcome gemcitabine resistance in pancreatic cancer?
22. Comparing extracellular vesicles from four different cell origins for intracellular drug delivery to pancreatic cancer cells: Small or large vesicles?
23. Production of Extracellular Vesicles Using a CELLine Adherent Bioreactor Flask
24. Challenges for gene editing in common variable immunodeficiency disorders: Current and future prospects
25. Soluble wild-type ACE2 molecules inhibit newer SARS-CoV-2 variants and are a potential antiviral strategy to mitigate disease severity in COVID-19
26. Synthesis of N-benzyl-des-D-ring lamellarin K via an acyl-Claisen/Paal-Knorr approach
27. Pyruvate anaplerosis is a mechanism of resistance to pharmacological glutaminase inhibition in triple-receptor negative breast cancer
28. Anti-apoptotic proteins in the autophagic world: an update on functions of XIAP, Survivin, and BRUCE
29. Phosphatidylcholine-Specific Phospholipase C as a Promising Drug Target
30. Synthesis and Anti-Proliferative Activity of 5-Benzoyl and 5-Benzylhydroxy Derivatives of 3-Amino-2-Arylcarboxamido-Thieno[2-3-b]Pyridines
31. Selected GRIN2A mutations in melanoma cause oncogenic effects that can be modulated by extracellular glutamate
32. Synthesis and cytotoxicity of thieno[2,3-b]quinoline-2-carboxamide and cycloalkyl[b]thieno[3,2-e]pyridine-2-carboxamide derivatives
33. Stability of trastuzumab during nanomedicine formulation using SEC-HPLC coupled with polyacrylamide gel electrophoresis
34. Investigation of 2-phenylimidazo[1,2-a]quinolines as potential antiproliferative agents
35. Synthesis of aza-derivatives of tetrahydrofuran lignan natural products
36. Haploinsufficiency of the NF-κB1 Subunit p50 in Common Variable Immunodeficiency
37. Synthesis and Anti-Proliferative Evaluation of Arctigenin Analogues with C-9′ Derivatisation
38. Identification of Extracellular Vesicles (Evs) from Different Cells for Intracellular Drug Delivery to Pancreatic Cancer Cells: Small or Large Evs?
39. Synthesis and cytotoxicity of thieno[2,3-b]pyridine and furo[2,3-b]pyridine derivatives
40. Impact of Coordination Mode and Ferrocene Functionalization on the Anticancer Activity of N-Heterocyclic Carbene Half-Sandwich Complexes
41. Critical role of diagnostic SARS-CoV-2 T cell assays for immunodeficient patients
42. A simple approach to re-engineering small extracellular vesicles to circumvent endosome entrapment
43. Leukocyte integrin α4β7 associates with heat shock protein 70
44. In vitro breast cancer models for studying mechanisms of resistance to endocrine therapy
45. Severe COVID-19 is a T cell immune dysregulatory disorder triggered by SARS-CoV-2
46. The (apparent) antibody paradox in COVID-19
47. The Regulatory Role of Long Noncoding RNAs in Cancer Drug Resistance
48. Disruption of Crystal Packing in Thieno[2,3-b]pyridines Improves Anti-Proliferative Activity
49. Conjugation of Palbociclib with MHI-148 Has an Increased Cytotoxic Effect for Breast Cancer Cells and an Altered Mechanism of Action
50. Common Variable Immunodeficiency Disorders as a Model for Assessing COVID-19 Vaccine Responses in Immunocompromised Patients
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.